Japanese Old Stories Cognitive Scale: a screening test to detect cognitive disease and prompt visiting a memory clinic

Psychogeriatrics : the Official Journal of the Japanese Psychogeriatric Society
Yasuyuki Honjo, Hajime Takechi

Abstract

Early detection and diagnosis is critical in enhancing treatment outcomes for those with cognitive disease. However, most Japanese patients are averse to visiting mental health clinics or taking cognitive screening examinations. A new simple screening test is needed that is acceptable to patients and encourages them to visit a memory clinic if indicated. We developed a brief screening examination, consisting of four common Japanese old stories, for detection of cognitive disease. A total of 311 patients at three outpatient memory clinics completed the screening test, responding to a 10-question, fill-in-the-blanks assessment. Questions were read aloud to patients with visual impairment, and we transcribed the spoken responses of patients who were physically incapable of writing. The Hasegawa Dementia Scale-Revised (HDS-R) and Mini-Mental State Examination (MMSE) were administered at the same time. Using the developed Japanese Old Stories Cognitive Scale (JOSS), we found significant differences between dementia and control or mild cognitive impairment (MCI) groups. The JOSS was less affected by education level than the HDS-R or MMSE, possibly because Japanese old stories are usually learned from family members during preschool y...Continue Reading

References

Nov 1, 1975·Journal of Psychiatric Research·M F FolsteinP R McHugh
Jul 21, 2012·American Journal of Alzheimer's Disease and Other Dementias·Yohko MakiHaruyasu Yamaguchi
Aug 29, 2014·Geriatrics & Gerontology International·Nayuta NamiokaToshihiko Iwamoto
Aug 8, 2015·Geriatrics & Gerontology International·Yuan-Han YangChing-Kuan Liu
Sep 14, 2017·Alzheimer's Research & Therapy·Marta Crous-BouJosé Luis Molinuevo
Jan 19, 2018·ClinicoEconomics and Outcomes Research : CEOR·William MontgomeryTomomi Nakamura

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: Early Markers

Alzheimer's disease (AD) is a neurodegenerative disease characterized by progressive cognitive and behavioral decline. Targeting markers in the earliest stages of the disease may mitigate the progression of AD. This feed focuses on early diagnosis and markers, as well as environmental, pharmacological, and drug-response biomarkers associated with this disease.